S D Retail Investor Presentation: Key Takeaways
H1 FY27 revenue ₹91.33 Cr (+16.6%), PAT ₹0.33 Cr (vs ₹0.13 Cr), EBITDA ₹2.06 Cr (-5.5%). EBO-led shift, store expansion to 84.
ALFA Filings
Every announcement, straight from the exchange
Every earnings call announcement on NSE and BSE that our alert engine sent, newest first. Each one has its own page with the summary, the key figures and the original filing.
Time
2,289 announcements with these filters
H1 FY27 revenue ₹91.33 Cr (+16.6%), PAT ₹0.33 Cr (vs ₹0.13 Cr), EBITDA ₹2.06 Cr (-5.5%). EBO-led shift, store expansion to 84.
Q2 FY27 revenue ₹514 Cr (-16% YoY), EBITDA ₹25 Cr at 4.8% margin, net profit ₹6 Cr. Record ₹5,001 Cr order book, up 48% YoY.
Q2FY27 total income Rs290 Cr (-10.8%), EBITDA Rs15 Cr, PAT Rs1 Cr turnaround on sugar realisation up 13%, despite lower volumes. H1 PAT -Rs11 Cr.
Q2 consolidated revenue ₹105.61 Cr (+102%), PAT ₹17.18 Cr (+84%). EBITDA margin recovered to 23.9%, still below the 25-30% guided band. FY27 revenue reiterated at ₹380-400 Cr.
Q2FY27 consolidated total income ₹821 Cr (+11% YoY), EBITDA ₹202 Cr (+41%, 25% margin), PAT ₹65 Cr (+14%). Controlling stake in Bliss GVS Pharma acquired 28 Sep 2026.
Record standalone revenue ₹2,526 Cr (+30% YoY), but consolidated EBITDA up only 9%. US loss-making, Europe at 3% margin; H2 recovery hinges on cost pass-through.
Revenue ₹1,592 Cr (+104% YoY, mostly TrueBridge consolidation) and EBITDA ₹442 Cr (~28%). Legacy IKS grew ~13% in USD. TrueBridge is flat for FY27, and management gives no growth guidance.
Q2 standalone revenue rose 38% and PAT 31%, helped by marketing fees. FY27 standalone revenue target reiterated despite slow H1 awards.
Management claims record profitability and AUM up ~95% YoY, but analyst-cited QoQ AUM growth was ~3%. Collection efficiency fell from ~98% to ~90%, with NPAs rising.
Q2 FY27 revenue Rs 852.4 Cr (+36% YoY), but EBITDA margin fell to 0.7% and PAT was -Rs 26.3 Cr on air-freight and input-cost overruns.
Q2 revenue +9.5% and PAT +30.4%, but H1 growth is price-aided and EBITDA margin slipped to 11.5%. Management hedges on H2 recovery and margins amid a steel cost surge; spares fell 4.7% in Q2.
Headline strong: consolidated PAT +57.7% to ₹45.3 Cr, EBITDA +27.5% to ₹100 Cr. Management sidestepped separator economics, timelines and Noida weakness; no quantified guidance.
Q2 FY27 volume grew ~15% and EBITDA margin recovered to 23% from 14.4% in Q1 after price hikes. Management guides FY27 revenue of ₹375-400 Cr. Q2 net profit was not disclosed on the call.
Q2 FY27 missed: consolidated revenue +8% YoY to ₹875 Cr, EBITDA down 19% to ₹87 Cr at 9.9% margin. Management admits Q2 was unsatisfactory and trimmed FY27 revenue guidance to 16-18% from 18-20%.
Q2 FY27 standalone revenue INR45,752 cr (+17%) and PAT INR5,320 cr (+14%); group H1 PAT +26%. NGEL H1 revenue +58% at 89% EBITDA margin. RE capacity addition slipping on transmission delays; thermal pipeline expanding.
H1 FY27 revenue INR12,824cr (+25.97%), PAT INR2,589cr (+14.80%), order book INR68,717cr. Management held guidance: 15%+ growth, ~28% EBITDA margin.
Revenue +60% YoY to ₹363.8 Cr, but margin fell to 20.6% and PAT dropped 20%. Management blames accounting timing and input costs, reiterates ₹2,000 Cr FY27 guidance despite rising debt and negative OCF.
Q2 FY27 revenue ₹209 Cr (+27% YoY), EBITDA margin 13.4%, PAT ₹13 Cr (+18%). Management hedges on geopolitics, block-2 timing and depreciation; segment figures are thin.
Q2 FY27 One Sudarshan revenue ₹2,743 Cr (+14.9% YoY), business EBITDA ₹239 Cr (8.7% margin, +4.7pp). Integration progressing; VP4 sale completed 2 Nov 2026.
H1 FY27 revenue ₹186.21 Cr (+89%) and PAT ₹84.27 Cr (+267%), driven by a large dredging win. Management calls Q2 seasonally soft, so H2 must deliver on pending tenders.
Strong Q2 FY27: revenue +42% YoY, PAT +48%, order book ₹2,000 Cr (+93% YoY). EBITDA margin slipped QoQ on commodity costs, and FY28 growth is guided lower at 10-15%. Management deflected on volume/price split and capacity utilisation.
Q2 FY27 revenue ₹1,083 Cr, +55% YoY, largely price pass-through; specialty margins fell on hedge fixed costs. Management upbeat, but evasive on spreads; working capital elevated.
Q2 revenue rose only 1.6% on a weak agro monsoon, but EBITDA margin widened to 13.3% on mix and procurement. Management guided subdued agro demand and H2 cost pressure, with no numeric outlook.
Record Q2 revenue ₹321 Cr (+25%) includes ~₹40 Cr one-time escalation; ₹27 Cr ECL and ₹20 Cr exceptional depress margins. Moshi still offline; DSO 114 days.
Consolidated revenue +13% YoY and EBITA +48% on a weak year-ago base. India +10%, Africa +32%. Volume growth is unquantified and key benefits are deferred to FY28.
Q2 revenue rose 14.1% to ₹135.6 Cr and EBITDA 23.9%, driven by occupancy and volume. Raipur break-even slipped from Q3 FY27 to Q1 FY28 amid ~₹9 Cr Q2 losses. Management gave no new quantified targets beyond FY27 growth.
Consolidated Q2 income fell 15% and posted a ₹118.96 Cr loss. Management cut its FY27 revenue target to flat-to-5% and hedged heavily.
Record Q2 revenue of ₹630.5 Cr (+14.3%) and PAT of ₹45.7 Cr (+25.3%) despite steeper inflation. EBITDA margin held flat QoQ at 13.1%, but management expects margin pressure to persist into Q3.
Q2 revenue rose 27.5% to ₹549.2 Cr and net loss narrowed to ₹15.2 Cr. Chemicals drove gains; sugar-ethanol remains loss-making and seasonal.
Q2 revenue ₹732 Cr, +16% YoY; H1 ₹1,410 Cr, +15%. EBITDA margin 19.7% despite ~₹6 Cr wage-revision hit. Trade-margin cap guided at mid-to-high single-digit annualised impact, with few specifics.